← Leaderboards
Serengulam V Govindan
Immunomedics, Inc.
$2,256,181
Attributed
$2,256,181
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2007–09$2M$1.5M$1M$500K$0
'07
'08
'09
Funding mix
By agency
NIH$2,256,181 · 5
By mechanism
R44$2,041,847 · 3
R43$214,334 · 2
Top collaborators
No co-investigators on record.
Most similar at Immunomedics, Inc.
Same institution · by research overlap
- William John McBride$1,257,246
- Chien Hsing K. Chang$1,347,339
- Hans J Hansen$696,895
- William A. Wegener$2,714,853
- Gary Leonard Griffiths$119,171
Others in their field
Top investigators on “Radiotracer”
- Robert H Mach · Wake Forest University$39,562,505
- Simon R Cherry · University Of California Los Angeles$17,948,135
- Joel Synes Perlmutter · Washington University$16,457,601
- Gwenn S Smith · Long Island Jewish Medical Center$16,008,680
- Richard E Carson · Yale University$15,174,693
- Rajesh Narendran · Columbia University Health Sciences$15,115,382
Research focus
RadiotracerScale UpAntibodiesMonoclonal AntibodiesRadiolabeledPreparationDoseInvestigational New Drug ApplicationLinkMonkeysAnimalsClinical TrialsPharmaceutical PreparationsPre-ClinicalNonhuman PrimateCyclic GmpEvaluationImmunoconjugatesChemotherapyLifeMacaca FascicularisMalignant NeoplasmsCell LineSmall Business Innovation Research Grant
Grant awards (7)
An anti-CD74 MAb-drug conjugate for B-cell malignancies$309,824
R44 · FY2009 · CA · contact PI
MAb-based targeted chemotherapy of lung cancer$239,702
R44 · FY2009 · CA · contact PI
MAb-based targeted chemotherapy of lung cancer$724,653
R44 · FY2008 · CA · contact PI
An anti-CD74 MAb-drug conjugate for B-cell malignancies$492,190
R44 · FY2008 · CA · contact PI
MAb-based targeted chemotherapy of lung cancer$114,334
R43 · FY2007 · CA · contact PI
Minimal-disease radioimmunotherapy of colorectal cancer$100,000
R43 · FY2003 · CA
IMPROVED RADIOIODINATION METHODS FOR RADIOIMMUNOTHERAPY$275,478
R44 · FY2000 · CA